期刊文献+

蛋白结合硫酸吲哚酚损伤红细胞膜 被引量:1

Albumin-bound indoxyl sulfate damages erythrocytes in vitro
下载PDF
导出
摘要 目的研究蛋白结合硫酸吲哚酚对红细胞寿命的影响及作用机制。方法以4%白蛋白结合不同浓度的硫酸吲哚酚孵育0.4%红细胞悬液48 h,采用流式细胞仪检测红细胞体积,Annexin-V-FITC凋亡试剂盒检测红细胞表面磷脂酰丝氨酸的标记率,钙离子荧光探针(Fluo3/AM)检测红细胞内Ca2+浓度,酶标分析仪检测红细胞的溶血率,采用SPSS18.0统计软件进行统计分析。结果 4%白蛋白结合硫酸吲哚酚孵育0.4%红细胞悬液48 h后,随硫酸吲哚酚浓度逐渐增加,红细胞体积逐渐变小[(1603.33±8.50)vs(742.67±14.04),P<0.05],红细胞表面磷脂酰丝氨酸的标记率[(0.26±0.06)vs(10.32±1.64),P<0.05]、红细胞内Ca2+浓度以及溶血率逐渐增加,与对照组相比差异有统计学意义(P<0.05),呈剂量依赖性;当细胞外Ca2+缺乏时,硫酸吲哚酚对红细胞的这种损伤效应明显降低。结论 4%白蛋白结合硫酸吲哚酚通过增加钙内流而损伤红细胞,促进红细胞衰亡,是尿毒症患者贫血的发生机制之一,清除蛋白结合毒素有助于改善贫血。 Objective To investigate the effect of albumin-bound indoxyl sulfate on erythrocytes and related mechanism.Methods Different concentrations of indoxyl sulfate were bound to 4% albumin.Erythrocytes with 0.4% hematocrit were prepared from normal adults.Forward scatter was used to estimate erythrocyte volume.Phosphatidylserine-exposure from annexin V binding was used to check eryptosis.Erythrocyte intracellular free calcium concentration([Ca^2 +]i) was detected by Fluo3-fluorescence and assayed by flow cytometry.Hemolysis from hemoglobin release was estimated with an enzyme-mark analyzer.Statistical analysis was made with SPSS18.0 software.Results Exposure to albumin-bound indoxyl sulfate for 48 hours significantly decreased erythrocyte volume(1603.33 ± 8.50 vs 742.67 ± 14.04,P 〈 0.05),and increased eryptosis(0.26 ± 0.06 vs 10.32 ± 1.64,P 〈 0.05),[Ca2 +]iand hemolysis ratio in a dose-dependent manner(P 〈 0.05).The damage effect of albumin-bound indoxyl sulfate on erythrocytes was weakened in the absence of Ca^2 +in the supernatant.Conclusion Albumin-bound indoxyl sulfate induces eryptosis through calcium influx,which is an important mechanism of anemia in uremic patients.Eliminating albumin-bound indoxyl sulfate might alleviate renal anemia.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2014年第24期2467-2470,共4页 Journal of Third Military Medical University
关键词 红细胞衰亡 硫酸吲哚酚 蛋白结合毒素 钙离子 eryptosis; indoxyl sulfate; albumin-bound toxin; calcium
  • 相关文献

参考文献18

  • 1Ruedin P,Dickenmann M,Martin P Y,et al. Management of renal anemia in patients with chronic kidney disease:the role of the general practitioner[J]. Rev Med Suisse,2012,8(323):70-73.
  • 2Palmer S C,Navaneethan S D,Craig J C,et al. Meta-analysis:erythropoiesis-stimulating agents in patients with chronic kidney disease[J]. Ann Intern Med,2010,153(1):23-33.
  • 3Staude H,Jeske S,Schmitz K,et al. Cardiovascular risk and mineral bone disorder in patients with chronic kidney disease[J]. Kidney Blood Press Res,2013,37(1):68-83.
  • 4Lang F,Gulbins E,Lerche H,et al. Eryptosis,a window to systemic disease[J]. Cell Physiol Biochem,2008,22(5/6):373-380.
  • 5Lang F,Gulbins E,Lang P A,et al. Ceramide in suicidal death of erythrocytes[J]. Cell Physiol Biochem,2010,26(1):21-28.
  • 6Lang F,Qadri S M. Mechanisms and significance of eryptosis,the suicidal death of erythrocytes[J]. Blood Purif,2012,33(1/3):125-130.
  • 7Abed M,Artunc F,Alzoubi K,et al. Suicidal erythrocyte death in end-stage renal disease[J]. J Mol Med(Berl),2014,92(8):871-879.
  • 8Popolo A,Autore G,Pinto A,et al. Oxidative stress in patients with cardiovascular disease and chronic renal failure[J]. Free Radic Res,2013,47(5):346-356.
  • 9Nguyen D B,Wagner-Britz L,Maia S,et al. Regulation of phosphatidylserine exposure in red blood cells[J]. Cell Physiol Biochem,2011,28(5):847-856.
  • 10Lang E,Qadri S M,Lang F. Killing me softly-suicidal erythrocyte death[J]. Int J Biochem Cell Biol,2012,44(8):1236-1243.

二级参考文献1

共引文献4

同被引文献14

  • 1Levey A S, Atkins R, Coresh J, et al. Chronic kidney dis- ease as a global public health problem: approaches and initia- tives-a position statement from Kidney Disease Improving Global Outcomes[J]. Kidney Int, 2007, 72(3): 247 -259.
  • 2Egbi O G, Ogunrin O, Oviasu E. Prevalence and determi- nants of cognitive impairment in patients with chronic kidney disease: a cross-sectional study in Benin City, Nigeria[ J ]. Ann Afr Med, 2015, 14(2): 75-81.
  • 3Seifter J L, Samuels M A. Uremic encephalopathy and other brain disorders associated with renal failure [ J ]. Semin Neurol, 2011, 31(2): 139-143.
  • 4Coekcroft D W, Gauh M H. Prediction of creatinine clearance from serum ereatinine[ J]. Nephron, 1976, 16(1) : 31 -41.
  • 5Etgen T, Sander D, Chonehol M, et al. Chronic kidney dis- ease is associated with incident cognitive impairment in the elderly: the INVADE study [ J ]. Nephrol Dial Transplant, 2009, 24(10) : 3144 -3150.
  • 6Baumgaertel M W, Kraemer M, Berlit P. Neurologic compli- cations of acute and chronic renal disease [ J ]. Handb Clin Neurol, 2014, 119:383 -393.
  • 7Bettini S, Lazzari M, Ferrando S, et al. Histopathological a- nalysis of the olfactory epithelium of zebrafish ( Danio rerio) exposed to sublethal doses of urea[J]. J Anat, 2016, 228 (1) : 59 -69.
  • 8Li R, Huang C, Chen J, et al. The role of uric acid as a po- tential neuroprotectant in acute ischemic stroke: a review of literature[J]. Neurol Sci, 2015, 36 (7): 1097 - 1103.
  • 9Fukae J, Ishikawa K, Hatano T, et al. Serum uric acid con- centration is linked to wearing-off fluctuation in Japanese Parkinson' s disease patients [ J]. J Parkinsons Dis, 2014, 4 (3) : 499 -505.
  • 10Fang P, Li X, Luo J J, et al. A Double-edged Sword: Uric Acid and Neurological Disorders [ J ]. Brain Disord Ther, 2013, 2(2) : 109.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部